🔎 Trials Near Me

Beranda › Overland Park, KS

Studi relawan sehat di Overland Park, KS

28 studi di lokasi sekitar Overland Park menerima relawan sehat — orang tanpa kondisi yang sedang diteliti. Banyak studi membayar peserta atas waktu dan perjalanan mereka; jumlah pembayaran ditentukan oleh masing-masing studi, jadi tanyakan kepada tim studi.

Teks studi resmi (Bahasa Inggris)

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Menerima pesertaSukarelawan sehat diterima
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
  • University of Kansas Clinical Research Center, Fairway · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07283939

A Study of Investigational RSV/hMPV Combination and Investigational hMPV Vaccines in Younger and Older Adults

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • GSK Investigational Site, Lenexa · 4 mi jauhnya
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07628049

Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male Participants

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Dr. Vince Clinical Research, Overland Park
Usia 18 hingga 55 · Pria · Diperbarui 25 Sep 2026 · NCT07744802

A Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Johnson County Clin-Trials, Lenexa · 4 mi jauhnya
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07425821

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Johnson County Clin-Trials, Lenexa · 4 mi jauhnya
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07565090

A Study of RO7890597 in Healthy Adult Volunteers

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON (LPRA) - Lenexa, Lenexa · 4 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07797478

Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy Participants

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Altasciences - Kansas City, Overland Park
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07283770

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

Menerima pesertaFase 3Sukarelawan sehat diterima
  • GSK Investigational Site, Lenexa · 4 mi jauhnya
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07805707

Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users

Menerima pesertaFase 4Sukarelawan sehat diterima
  • Dr. Vince Clinical Research, Overland Park
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07813026

A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON Early Phase Services, LLC, Lenexa · 4 mi jauhnya
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07767175

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • KCCC Overland Park, Overland Park
  • Overland Park Regional Medical Center, Overland Park
Semua usia · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT02302742

First Time in Human Study of Long Acting VH4524184 Formulations

Menerima pesertaFase 1Sukarelawan sehat diterima
  • GSK Investigational Site, Lenexa · 4 mi jauhnya
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06310551

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON Early Phase Services, LLC, Lenexa · 4 mi jauhnya
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07437079

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Atea Study Site, Overland Park
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT07314346

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Lenexa Research Unit, Lenexa · 4 mi jauhnya
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT07626281

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON, Clinical Research Phase I Unit, Lenexa · 4 mi jauhnya
Usia 18 hingga 55 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT06733675

Integrated Cancer Repository for Cancer Research

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Saint Luke's Cancer Instititute - South, Overland Park
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Menerima pesertaFase 3Sukarelawan sehat diterima
  • Invivyd Investigative Site, Overland Park
Usia 18 hingga 49 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07655180

First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Altasciences Inc - Kansas City, Overland Park
Usia 18 hingga 59 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07169318

Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis, Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate, Contraindicated or Declined

Menerima pesertaFase awal 1Sukarelawan sehat diterima
  • The University of Kansas Cancer Center, Fairway · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT06414681

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Menerima pesertaFase 1/2Sukarelawan sehat diterima
  • GSK Investigational Site, Lenexa · 4 mi jauhnya
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06702449

A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON - Lenexa, Lenexa · 4 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT07204418

Abuse Liability for Five Modern Oral Nicotine Products

Menerima pesertaSukarelawan sehat diterima
  • Dr. Vince Clinical Research, Overland Park
Usia 21 hingga 60 · Semua jenis kelamin · Diperbarui 30 Des 2025 · NCT07132814

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Menerima pesertaSukarelawan sehat diterima
  • University of Kansas Medical Center, Fairway · 3 mi jauhnya
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT06728436

A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers

Menerima pesertaFase 1Sukarelawan sehat diterima
  • Dr. Vince Clinical Research, Overland Park
Usia 23 hingga 59 · Semua jenis kelamin · Diperbarui 15 Okt 2025 · NCT07215923

A Study of IBI3032 in Healthy Participants

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON Clinical Research, Lenexa · 4 mi jauhnya
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 17 Sep 2025 · NCT07120425

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Menerima pesertaFase 1Sukarelawan sehat diterima
  • ICON Clinical Research: Lenexa, Lenexa · 4 mi jauhnya
Usia 18 hingga 55 · Pria · Diperbarui 27 Agu 2025 · NCT07093580

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis

Menerima pesertaSukarelawan sehat diterima
  • University of Kansas Clinical Research Center, Fairway · 3 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Apr 2025 · NCT06064695

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.